Low Testosterone and Erectile Dysfunction: What Is the Connection?

How are testosterone and erectile function related?

Testosterone influences sexual function through at least two pathways. First, it drives sexual desire (libido) — men with low testosterone often notice reduced interest in sex before they notice changes in erection quality. Second, testosterone receptors exist in penile tissue and may influence the nitric oxide signaling that allows erection to occur, though this relationship is more complex than simple deficiency causing direct failure.

The AUA guideline on erectile dysfunction acknowledges testosterone deficiency as one of several contributing factors to ED, but emphasizes that its relative contribution varies considerably across individuals 1Ref 1Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh J, Khera M, McVary KT, Miner MM, Nelson CJ, Sadeghi-Nejad H, Seftel AD, Shindel AW (2018).Erectile Dysfunction: AUA Guideline.Testosterone as one of several contributing factors to ED; evaluation framework; cardiovascular risk linkage. Clinical experience suggests that pure low-testosterone ED — where restoring testosterone resolves the problem — is the exception rather than the rule.

What causes erectile dysfunction beyond low testosterone?

Erections require coordinated function of blood vessels, nerves, hormones, and psychology. The most common contributors to ED are:

Vascular disease — the most common underlying factor in men over 40. The arteries supplying the penis are small; atherosclerosis reduces blood flow before it becomes apparent in larger coronary vessels. ED can be an early warning sign of cardiovascular disease.

Neurological factors — diabetes-related neuropathy, multiple sclerosis, Parkinson disease, or pelvic nerve injury from prostate surgery.

Psychological factors — performance anxiety, depression, relationship stress, and trauma. Psychological ED can coexist with organic causes, making both harder to treat.

Medications — antidepressants (especially SSRIs), antihypertensives (particularly beta-blockers and some diuretics), antihistamines, opioids, and finasteride are among the medications most commonly linked to ED.

Lifestyle factors — smoking, excessive alcohol, sedentary lifestyle, and obesity all increase ED risk.

Because so many factors contribute, evaluation that focuses only on testosterone misses most of what is driving the problem in most men.

When does testosterone actually matter for ED?

Testosterone is most likely to be a meaningful contributor when:

• Low libido (reduced sexual desire) is the primary complaint, more than difficulty with erection mechanics
• Testosterone levels are confirmed to be low on appropriately timed lab testing (see hs-1251)
• Other contributing factors have been addressed or ruled out
• The man has documented hypogonadism (primary or secondary testicular failure)

The Endocrine Society clinical practice guideline on testosterone therapy in hypogonadism notes that testosterone therapy can improve libido and, in some men with hypogonadism, erectile function — but should be initiated only when low levels are confirmed and a clear indication exists 2Ref 2Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MA (2018).Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.Testosterone therapy improving libido and sexual function in hypogonadal men when confirmed low levels are present.

PDE5 inhibitors (such as sildenafil and tadalafil) work through a different mechanism — enhancing blood flow regardless of testosterone status — and are the first-line pharmacological treatment for most ED 3Ref 3Pyrgidis N, Mykoniatis I, Haidich AB, Tirta M, Talimtzi P, Kalyvianakis D, Ouranidis A, Hatzichristou D (2021).The Effect of Phosphodiesterase-type 5 Inhibitors on Erectile Function: An Overview of Systematic Reviews.PDE5 inhibitors as first-line pharmacological treatment for most ED. In men with both low testosterone and ED who do not respond adequately to PDE5 inhibitors, testosterone therapy may be added.

How is ED evaluated by a clinician?

A thorough evaluation typically includes:

• A detailed history: onset (gradual vs. sudden), presence of nocturnal erections, relationship to specific situations, medication list, and overall health
• Physical examination including blood pressure and cardiovascular assessment
• Lab tests: fasting glucose, HbA1c, lipid panel, and testosterone (morning, repeated if abnormal)
• Sometimes: thyroid function, prolactin, and PSA depending on clinical context

The AUA ED guideline emphasizes that ED itself is a marker of cardiovascular risk and that a clinician finding significant ED — especially in a man under 60 — should evaluate cardiovascular health, not just treat the symptom 1Ref 1Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh J, Khera M, McVary KT, Miner MM, Nelson CJ, Sadeghi-Nejad H, Seftel AD, Shindel AW (2018).Erectile Dysfunction: AUA Guideline.Testosterone as one of several contributing factors to ED; evaluation framework; cardiovascular risk linkage.

What are the treatment options?

Treatment is tailored to the identified causes:

• Lifestyle changes: Regular exercise, smoking cessation, reduced alcohol, and weight loss improve erectile function and are often recommended as the first step regardless of other causes.
• PDE5 inhibitors (sildenafil, tadalafil, vardenafil, avanafil): First-line pharmacological therapy for most ED. They work by enhancing nitric oxide-mediated relaxation of penile smooth muscle. Multiple systematic reviews confirm their efficacy 3Ref 3Pyrgidis N, Mykoniatis I, Haidich AB, Tirta M, Talimtzi P, Kalyvianakis D, Ouranidis A, Hatzichristou D (2021).The Effect of Phosphodiesterase-type 5 Inhibitors on Erectile Function: An Overview of Systematic Reviews.PDE5 inhibitors as first-line pharmacological treatment for most ED.
• Testosterone replacement therapy (TRT): For confirmed hypogonadism, TRT can improve libido and in some cases erectile function. It carries its own considerations including effects on fertility and erythrocytosis (elevated red blood cell count).
• Psychological support: Cognitive behavioral therapy and couples therapy are effective when psychological factors are prominent.
• Second-line options: Vacuum erection devices, penile injections (alprostadil), intraurethral suppositories, and surgery are considered when first-line treatments fail.

A primary care clinician is the right starting point. Urologists and endocrinologists manage more complex cases.